Latest congenital heart disease Stories
ATLANTA, Oct. 13, 2011 /PRNewswire/ -- CryoLife, Inc. (NYSE: CRY), a leading tissue processing and medical device company focused on cardiac and vascular surgery, announced today that ValveXchange, Inc., a company in which CryoLife owns a minority interest, has completed the first three human implants with its novel Vitality(TM) two-part heart valve system. The surgeries were performed in Asuncion, Paraguay and took place on Sept. 26 and 27, 2011. Three men aged 49, 62 and 72 received the...
The US Secretary of Health recently supported a recommendation that all babies born in the US are to be screened for critical heart defects, before leaving hospital. Behind this decision is a study from the Sahlgrenska Academy at the University of Gothenburg, and the West Götaland Region's maternity units in Sweden which shows that a simple test can save the lives of newborns with these heart defects. Other countries too are set to make the test mandatory. One or two out of every thousand...
JENA, Germany, September 26, 2011 /PRNewswire/ -- Occlutech, a leading European developer of implants for treating structural heart disease today announced that its CEO, Mr Tor Peters, has obtained a favorable ruling from the district court in Duesseldorf in patent litigation initiated personally against him by St Jude AGA Medical. On the 10th of May 2011, Occlutech GmbH won an over 5 years long patent lawsuit initiated by St Jude-AGA Medical at the German Supreme Court...
IRVINE, Calif., Sept. 23, 2011 /PRNewswire/ -- Masimo (NASDAQ: MASI) announced today that the U.S. Department of Health & Human Services (HHS) has added Critical Congenital Heart Defects (CCHD) screening using motion-tolerant pulse oximetry as a national newborn screening standard. In addition, the largest UK study of pulse oximetry screening for CHD detection, published online in the Lancet (appearing in the November 2011 print edition), demonstrates that when Masimo SET®...
MEMPHIS, Tenn., Sept. 8, 2011 /PRNewswire-USNewswire/ -- International Children's Heart Foundation (ICHF) announced today that they will be expanding and nationalizing their program in the Dominican Republic to include Santo Domingo beginning September 2011. ICHF is a non-profit organization dedicated to providing lifesaving surgical care to children with congenital heart disease throughout the developing world. ICHF, which already serves the Dr. Arturo Grullon Regional Children's Hospital...
Babies and toddlers with congenital heart disease are at an increased risk of having harmful toxins in their blood, particularly following surgery, according to research by a team at Imperial College London. The study, published today in the American Journal of Respiratory and Critical Care Medicine, found that children with high levels of toxins from gut bacteria in their blood are likely to take longer to recover from surgery and spend more time in intensive care. The researchers say...
JENA, Germany, August 24, 2011 /PRNewswire/ -- Occlutech, a leading European developer of medical implants treating structural heart disease such as PFO, ASD and LAA today announced the closing of a 15 million Euro investment into Occlutech. The investment was lead by Hong Kong based Interlink Investments Ltd. and subscribed by investors as well as Occlutech distribution partners from Japan, Switzerland, Ireland, Austria and Turkey. Tor Peters, CEO, said in a statement;...
Pediatric Heart Network sites to focus on improving outcomes for babies born with congenital heart disease ANN ARBOR, Mich., Aug. 19, 2011 /PRNewswire-USNewswire/ -- The University of Michigan Congenital Heart Center has been selected as a new Pediatric Heart Network core site for clinical research. Created and funded by the National Heart, Lung, and Blood Institute, part of the National Institutes of Health, the Pediatric Heart Network is a cooperative network of pediatric cardiovascular...
TUCSON, Ariz., Aug. 17, 2011 /PRNewswire/ -- SynCardia Systems, Inc. (www.syncardia.com), manufacturer of the SynCardia temporary Total Artificial Heart, announced today that University of Muenster in Germany has successfully bridged its first patient to transplant with the Total Artificial Heart after 89 days of support. (Photo: http://photos.prnewswire.com/prnh/20110817/LA53549) On Jan. 14, 60-year-old Jan Detert was admitted to University of Muenster as an emergency heart attack case...
(Ivanhoe Newswire) -- A quick, non-invasive test that measures blood oxygen levels in newborns detects more cases of life-threatening congenital heart defects than current standard approaches and should be adopted into the routine assessment of all newborns before discharge from hospital, according to this study.Congenital heart defects are one of the leading causes of deaths in infants in the developed world. Current screening techniques involving a mid-trimester ultrasound scan and a...
